FdaApplication

ANDA 214180

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2021-11-19

Products (3)

ProductActive ingredientStrengthDosage form
DEFERASIROXDEFERASIROX90MGGRANULE;ORAL
DEFERASIROXDEFERASIROX360MGGRANULE;ORAL
DEFERASIROXDEFERASIROX180MGGRANULE;ORAL

3 products